The efficacy of mometasone furoate for children with asthma: a meta-analysis of randomized controlled trials

Song, Yanling; Pan, Kaiyu; Chen, Yuyan; Wang, Xiaoming; Tian, Jun

doi:10.5114/ada.2020.93273

Cited by 1 publication

(1 citation statement)

References 36 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…The control group in this study used kenalog, a common topical glucocorticoid, which has strong anti-itch, anti-inflammatory, anti-allergic, vasoconstrictive and cell division inhibition effects. It can reduce local inflammation in children and shrink adenoid tissue to relieve clinical symptoms such as nasal congestion and runny nose [17] . Montelukast sodium can block the combination of leukotriene's and receptors produced by the body's cells induced by external pathogenic factors, thus blocking airway inflammation and improving mucosal edema, reducing adenoid growth, and decreasing secretions [18] .…”

Section: Basic Data Informationmentioning

confidence: 99%

Comparative Study of Montelukast and Mometasone Furoate in the Treatment of Pediatric Obstructive Sleep Apnea Syndrome

Xing,

Wu,

Zhu

et al. 2023

IJPS

View full text Add to dashboard Cite

This study aimed to compare the efficacy of combined treatment with kenacort and montelukast vs. surgical treatment using low temperature plasma radiofrequency ablation in children with snoring. 70 children with snoring were selected as the study subjects at our hospital and all children met the inclusion criteria. According to the different treatments received by the children, the control group (n=35) received combined treatment with kenacort and montelukast, while the observation group (n=35) underwent surgery (low temperature plasma radiofrequency ablation). The clinical treatment effects, degree of adenoid hypertrophy, symptom improvement, ventilator function, sleep quality and quality of life were compared between the two groups of children. The total effective rate of treatment in the control group was 71.43 %, while that in the observation group was 94.29 %, which was significantly higher than that in the control group (p<0.05). Before treatment, there was no significant difference in the adenoid-nasopharyngeal ratio between the two groups (p>0.05). After treatment, the adenoidnasopharyngeal ratio in the observation group was significantly lower than that in the control group (p<0.05). Before treatment, there was no significant difference in the symptom score between the two groups (p>0.05). After treatment, the symptom score in the observation group was significantly lower than that in the control group (p<0.05). Before treatment, there was no significant difference in the LAT, oxygen desaturation index 4 % and apnea-hypopnea index levels between the two groups (p>0.05). After treatment, the LAT, oxygen desaturation index 4 % and apnea-hypopnea index levels in the observation group were significantly lower than those in the control group (p<0.05). Before treatment, there was no significant difference in the Pittsburgh sleep quality index score and obstructive sleep apnea-1 score between the two groups (p>0.05). After treatment, the Pittsburgh sleep quality index score and obstructive sleep apnea-1 score in the observation group were significantly lower than those in the control group (p<0.05). Compared with combined treatment with kenacort and montelukast, low-temperature plasma radiofrequency ablation is more effective for children with snoring and surgical treatment can better improve the clinical symptoms and ventilator function of children, thereby further improving their sleep quality and quality of life.

show abstract

Section: Basic Data Informationmentioning

confidence: 99%